Consistent with the results from pre-clinical animal studies, the effectiveness of etanercept, a humanized soluble TNF receptor fusion protein that neutralizes the effects of TNF-α, has been inconsistent in the treatment of asthma [112]. The gene discussed is TNF; the disease is asthma.